Interplay between MEK-ERK signaling, cyclin D1, and cyclin-dependent kinase 5 regulates cell cycle reentry and apoptosis of neurons

Molecular Biology of the Cell

Volumn 23, Issue 18, 2012, Pages 3722-3730

  Modi, Prashant Kumar ^a   Komaravelli, Narayana ^a   Singh, Neha ^a   Sharma, Pushkar ^a  

^a NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CYCLIN D1; CYCLIN DEPENDENT KINASE 5; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PROTEIN P35;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CYCLE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME INHIBITION; INTRACELLULAR SIGNALING; NERVE CELL; NERVE CELL NECROSIS; NONHUMAN; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; RAT;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMYLOID BETA-PEPTIDES; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; BUTADIENES; CELL CYCLE; CELL CYCLE PROTEINS; CELLS, CULTURED; CYCLIN D1; CYCLIN-DEPENDENT KINASE 5; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HEK293 CELLS; HUMANS; MAP KINASE SIGNALING SYSTEM; MICROSCOPY, FLUORESCENCE; MITOGEN-ACTIVATED PROTEIN KINASES; NEURONS; NITRILES; PC12 CELLS; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; RNA INTERFERENCE;

EID: 84866385935     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E12-02-0125     Document Type: Article

References (55)

1. Bonni A, Brunet A, West AE, Datta SR, Takasu MA, Greenberg ME (1999). Cell survival promoted by the Ras-MAPK signaling pathway by transcription- dependent and -independent mechanisms. Science 286, 1358-1362.
2. Chae T, Kwon YT, Bronson R, Dikkes P, Li E, Tsai LH (1997). Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality. Neuron 18, 29-42. (Pubitemid 27053828)
3. Cheung ZH, Gong K, Ip NY (2008). Cyclin-dependent kinase 5 supports neuronal survival through phosphorylation of Bcl-2. J Neurosci 28, 4872-4877.
4. Cheung ZH, Ip NY (2004). Cdk5: mediator of neuronal death and survival. Neurosci Lett 361, 47-51. (Pubitemid 38609213)
5. Chong YH, Shin YJ, Lee EO, Kayed R, Glabe CG, Tenner AJ (2006). ERK1/2 activation mediates Abeta oligomer-induced neurotoxicity via caspase-3 activation and tau cleavage in rat organotypic hippocampal slice cultures. J Biol Chem 281, 20315-20325. (Pubitemid 44065806)
6. Cicero S, Herrup K (2005). Cyclin-dependent kinase 5 is essential for neuronal cell cycle arrest and differentiation. J Neurosci 25, 9658-9668. (Pubitemid 41510906)
7. Copani A, Condorelli F, Caruso A, Vancheri C, Sala A, Giuffrida Stella AM, Canonico PL, Nicoletti F, Sortino MA (1999). Mitotic signaling by beta-amyloid causes neuronal death. FASEB J 13, 2225-2234.
8. Cruz JC, Tseng HC, Goldman JA, Shih H, Tsai LH (2003). Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. Neuron 40, 471-483. (Pubitemid 37494698)
9. Dhavan R, Tsai LH (2001). A decade of CDK5. Nat Rev Mol Cell Biol 2, 749-759. (Pubitemid 33679837)
10. Ginty DD, Bonni A, Greenberg ME (1994). Nerve growth factor activates a Ras-dependent protein kinase that stimulates c-fos transcription via phosphorylation of CREB. Cell 77, 713-725. (Pubitemid 24175607)
11. Giovanni A, Wirtz-Brugger F, Keramaris E, Slack R, Park DS (1999). Involvement of cell cycle elements, cyclin-dependent kinases, pRb, and E2F x DP, in B-amyloid-induced neuronal death. J Biol Chem 274, 19011-19016.
12. Guidato S, McLoughlin DM, Grierson AJ, Miller CC (1998). Cyclin D2 interacts with cdk-5 and modulates cellular cdk-5/p35 activity. J Neurochem 70, 335-340. (Pubitemid 28020860)
13. Harper SJ, Wilkie N (2003). MAPKs: new targets for neurodegeneration. Expert Opin Ther Targets 7, 187-200. (Pubitemid 36512020)
14. Herrup K (2010). The involvement of cell cycle events in the pathogenesis of Alzheimer's disease. Alzheimers Res Ther 2, 13.
15. Herrup K, Busser JC (1995). The induction of multiple cell cycle events precedes target-related neuronal death. Development 121, 2385-2395.
16. Herrup K, Yang Y (2007). Cell cycle regulation in the postmitotic neuron: oxymoron or new biology? Nat Rev Neurosci 8, 368-378. (Pubitemid 46652467)
17. Hisanaga S, Endo R (2010). Regulation and role of cyclin-dependent kinase activity in neuronal survival and death. J Neurochem 115, 1309-1321.
18. Hoglinger GU et al. (2007). The pRb/E2F cell-cycle pathway mediates cell death in Parkinson's disease. Proc Natl Acad Sci USA 104, 3585-3590. (Pubitemid 46364202)
19. Ino H, Chiba T (2001). Cyclin-dependent kinase 4 and cyclin D1 are required for excitotoxin-induced neuronal cell death in vivo. J Neurosci 21, 6086-6094. (Pubitemid 32737742)
20. Klein EA, Assoian RK (2008). Transcriptional regulation of the cyclin D1 gene at a glance. J Cell Sci 121, 3853-3857.
21. Ko J, Humbert S, Bronson RT, Takahashi S, Kulkarni AB, Li E, Tsai LH (2001). p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment. J Neurosci 21, 6758-6771. (Pubitemid 32781119)
22. Kranenburg O, van der Eb AJ, Zantema A (1996). Cyclin D1 is an essential mediator of apoptotic neuronal cell death. EMBO J 15, 46-54. (Pubitemid 26020387)
23. Lavoie JN, L'Allemain G, Brunet A, Muller R, Pouyssegur J (1996). Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J Biol Chem 271, 20608-20616. (Pubitemid 26281839)
24. Lee MS, Kwon YT, Li M, Peng J, Friedlander RM, Tsai LH (2000). Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405, 360-364. (Pubitemid 30337070)
25. Leslie K et al. (2006). Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3. Cancer Res 66, 2544-2552.
26. Li BS, Zhang L, Takahashi S, Ma W, Jaffe H, Kulkarni AB, Pant HC (2002). Cyclin-dependent kinase 5 prevents neuronal apoptosis by negative regulation of c-Jun N-terminal kinase 3. EMBO J 21, 324-333. (Pubitemid 34137294)
27. Lonze BE, Ginty DD (2002). Function and regulation of CREB family transcription factors in the nervous system. Neuron 35, 605-623. (Pubitemid 35229980)
28. Malik B, Currais A, Andres A, Towlson C, Pitsi D, Nunes A, Niblock M, Cooper J, Hortobagyi T, Soriano S (2008). Loss of neuronal cell cycle control as a mechanism of neurodegeneration in the presenilin-1 Alzheimer's disease brain. Cell Cycle 7, 637-646. (Pubitemid 351499003)
29. Ng YP, Cheung ZH, Ip NY (2006). STAT3 as a downstream mediator of Trk signaling and functions. J Biol Chem 281, 15636-15644. (Pubitemid 43848449)
30. Ohshima T, Ward JM, Huh CG, Longenecker G, Veeranna, Pant HC, Brady RO, Martin LJ, Kulkarni AB (1996). Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc Natl Acad Sci USA 93, 11173-11178. (Pubitemid 26333137)
31. Park DS, Levine B, Ferrari G, Greene LA (1997a). Cyclin dependent kinase inhibitors and dominant negative cyclin dependent kinase 4 and 6 promote survival of NGF-deprived sympathetic neurons. J Neurosci 17, 8975-8983. (Pubitemid 27498426)
32. Park DS, Morris EJ, Bremner R, Keramaris E, Padmanabhan J, Rosenbaum M, Shelanski ML, Geller HM, Greene LA (2000a). Involvement of retinoblastoma family members and E2F/DP complexes in the death of neurons evoked by DNA damage. J Neurosci 20, 3104-3114. (Pubitemid 30263127)
33. Park DS, Morris EJ, Greene LA, Geller HM (1997b). G1/S cell cycle blockers and inhibitors of cyclin-dependent kinases suppress camptothecin-induced neuronal apoptosis. J Neurosci 17, 1256-1270. (Pubitemid 27073728)
34. Park DS, Morris EJ, Stefanis L, Troy CM, Shelanski ML, Geller HM, Greene LA (1998). Multiple pathways of neuronal death induced by DNA-damaging agents, NGF deprivation, and oxidative stress. J Neurosci 18, 830-840. (Pubitemid 28112906)
35. Park DS, Obeidat A, Giovanni A, Greene LA (2000b). Cell cycle regulators in neuronal death evoked by excitotoxic stress: implications for neurodegeneration and its treatment. Neurobiol Aging 21, 771-781.
36. Patrick GN, Zukerberg L, Nikolic M, de la Monte S, Dikkes P, Tsai LH (1999). Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402, 615-622. (Pubitemid 129516324)
37. Peterson DW, Ando DM, Taketa DA, Zhou H, Dahlquist FW, Lew J (2010). No difference in kinetics of tau or histone phosphorylation by CDK5/p25 versus CDK5/p35 in vitro. Proc Natl Acad Sci USA 107, 2884-2889.
38. Riccio A, Ahn S, Davenport CM, Blendy JA, Ginty DD (1999). Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons. Science 286, 2358-2361. (Pubitemid 30016901)
39. Selkoe DJ (1998). The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol 8, 447-453.
40. Sharma M, Hanchate NK, Tyagi RK, Sharma P (2007). Cyclin dependent kinase 5 (Cdk5) mediated inhibition of the MAP kinase pathway results in CREB down regulation and apoptosis in PC12 cells. Biochem Biophys Res Commun 358, 379-384. (Pubitemid 46755720)
41. Sharma P, Veeranna, Sharma M, Amin ND, Sihag RK, Grant P, Ahn N, Kulkarni AB, Pant HC (2002). Phosphorylation of MEK1 by cdk5/p35 down-regulates the mitogen-activated protein kinase pathway. J Biol Chem 277, 528-534.
42. Stanciu M et al. (2000). Persistent activation of ERK contributes to glutamate-induced oxidative toxicity in a neuronal cell line and primary cortical neuron cultures. J Biol Chem 275, 12200-12206. (Pubitemid 30237798)
43. Subramaniam S, Zirrgiebel U, Bohlen Und Halbach O, Strelau J, Laliberte C, Kaplan DR, Unsicker K (2004). ERK activation promotes neuronal degeneration predominantly through plasma membrane damage and independently of caspase-3. J Cell Biol 165, 357-369. (Pubitemid 38649911)
44. Sumrejkanchanakij P, Tamamori-Adachi M, Matsunaga Y, Eto K, Ikeda MA (2003). Role of cyclin D1 cytoplasmic sequestration in the survival of postmitotic neurons. Oncogene 22, 8723-8730. (Pubitemid 38010496)
45. Tandon A et al. (2003). Brain levels of CDK5 activator p25 are not increased in Alzheimer's or other neurodegenerative diseases with neurofibrillary tangles. J Neurochem 86, 572-581. (Pubitemid 36897438)
46. Taniguchi S, Fujita Y, Hayashi S, Kakita A, Takahashi H, Murayama S, Saido TC, Hisanaga S, Iwatsubo T, Hasegawa M (2001). Calpain-mediated degradation of p35 to p25 in postmortem human and rat brains. FEBS Lett 489, 46-50. (Pubitemid 32176003)
47. Veeranna, Amin ND, Ahn NG, Jaffe H, Winters CA, Grant P, Pant HC (1998). Mitogen-activated protein kinases (Erk1,2) phosphorylate Lys-Ser-Pro (KSP) repeats in neurofilament proteins NF-H and NF-M. J Neurosci 18, 4008-4021.
48. Wan J, Fu AK, Ip FC, Ng HK, Hugon J, Page G, Wang JH, Lai KO, Wu Z, Ip NY (2010). Tyk2/STAT3 signaling mediates beta-amyloid-induced neuronal cell death: implications in Alzheimer's disease. J Neurosci 30, 6873-6881.
49. Wen Z, Zhong Z, Darnell JE Jr (1995). Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82, 241-250.
50. Xiong Y, Zhang H, Beach D (1992). D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 71, 505-514.
51. Yang Y, Geldmacher DS, Herrup K (2001). DNA replication precedes neuronal cell death in Alzheimer's disease. J Neurosci 21, 2661-2668. (Pubitemid 32298208)
52. Zhang J, Cicero SA, Wang L, Romito-Digiacomo RR, Yang Y, Herrup K (2008). Nuclear localization of Cdk5 is a key determinant in the postmitotic state of neurons. Proc Natl Acad Sci USA 105, 8772-8777. (Pubitemid 351987755)
53. Zhang J, Herrup K (2011). Nucleocytoplasmic Cdk5 is involved in neuronal cell cycle and death in post-mitotic neurons. Cell Cycle 10, 1208-1214.
54. Zhang J, Li H, Yabut O, Fitzpatrick H, D'Arcangelo G, Herrup K (2010). Cdk5 suppresses the neuronal cell cycle by disrupting the E2F1-DP1 complex. J Neurosci 30, 5219-5228.
55. Zheng YL, Li BS, Kanungo J, Kesavapany S, Amin N, Grant P, Pant HC (2007). Cdk5 Modulation of mitogen-activated protein kinase signaling regulates neuronal survival. Mol Biol Cell 18, 404-413. (Pubitemid 46213211)